semaglutide for alcohol abuse JAMA - Most viewed this week from JAMA Psychiatry: Low-dose reduced craving and consumption in adults with alcohol use disorder. https://ja.ma/3Zlxi1c Popular weight loss drug could

Recent investigations have explored the therapeutic potential of GLP-1 in cardiovascular disease, metabolic-associated fatty liver disease, Parkinsons disease, and AD

#Obesity #GLP1 #BehaviouralMedicine #dietetics To view or add a comment, sign in New consensus statement, out this week in The Lancet Diabetes & Endocrinology, from European Association for the Study of Obesity (EASO), The European Federation of the Associations of Dietitians (EFAD) and ECPObesity: "Nutritional, functional, and psychological considerations for incretin-based therapies in adults." Link in comments

But the early results are tantalizing

The Precision Peptide Genetic Test ($99 add-on after month one) analyzes your GLP1R, FTO, GIPR, and MC4R variants across 14 pathways and 150+ genetic insights, revealing your metabolic and inflammatory predispositions

Individuals with personal or familial histories of medullary thyroid cancer, multiple endocrine neoplasia syndrome type II, pancreatitis, or severe gastrointestinal issues should explore alternatives with their providers

On the chemical mechanism of gastric secretion (Abstract) Proc Roy Soc Lond